NFKB1 and breast carcinoma: This is cliniclaly relevant since the TNF-induced angiogenesis inhibitor thalidomide is used for treatment of cancers [3-5], and since the TNF-induced activation of NF-κB transcripional programs that occurs in breast cancer and cultured endothelial cells appear very similar [22].